Rapamycin is considered by most longevity scientists and geroscience researchers to be the “gold standard” of longevity drugs; with healthy lifespan improvement typically in the range of 15% to 30%, and as high as 37% when combined with another longevity drug “Acarbose”. While these results have been in animals, there are many early indications that these benefits may also translate to people. B…